Compare Humana Inc (HUM) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Prologis Inc — how do they compare? Humana Inc trades at $406.53 (market cap $47.81B), while Prologis Inc trades at $149.44 (market cap $137.50B). The key difference: Prologis Inc is far larger — about 2.9× Humana Inc's market cap, and Prologis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals.
| HUM | PLD | |
|---|---|---|
Market Cap | $47.81B | $137.50B |
Sector | Health | Real Estate |
52-Week High | $409.42 | $149.96 |
52-Week Low | $163.67 | $104.08 |
Enterprise Value | $56.85B | $172.18B |
Dividend Yield | 0.89% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Prologis (PLD) trades at $147.17, down 1.7% on the day, with strong technical momentum showing bullish moving averages and key support at $146. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.13 beating expectations of $0.747, and maintains healthy profitability with 41.54% net income margin. Recent news highlights Prologis' aggressive expansion strategy with multiple takeover bids for SEGRO valued at $18.2 billion.
The outlook remains positive with analyst consensus at Buy (57% of coverage) and $156.56 price target representing 6.4% upside. Key opportunities include data center expansion and record leasing activity, while risks involve elevated valuation multiples (P/E 33.36) and increasing debt levels (debt-to-asset ratio rising to 37.2% in 2025).
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
